Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 0
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £0
Lisa Baderoon 583,963 £0
Tim Franklin 525,000 £0

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £0
Luca & Associates AG 22,000,000 £0
Invesco Ltd 17,872,341 £0
Aviva Investors Global 11,285,180 £0
Alora Pharmaceuticals LLC 10,909,091 £0
M&G Investments 7,600,000 £0
Prudential plc 7,600,000 £0
Capital Income Builder 4,870,367 £0
Dr R Zimmer 4,551,553 £0
Odey Asset Management 3,433,319 £0
Rhone Trustees (Switzerland) SA 3,386,000 £0
Pictet Overseas Trust Corporation Limited 3,287,500 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 5.90
52 Week Low 1.09
Volume 0
Shares Issued 499.72m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.17% below the market average29.17% below the market average29.17% below the market average29.17% below the market average29.17% below the market average
30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average
Price Trend
7.35% below the market average7.35% below the market average7.35% below the market average7.35% below the market average7.35% below the market average
42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 04-Aug-2025

Time Volume / Share Price
15:49 46,232 @ 2.15p
15:39 60,000 @ 2.05p
15:39 160,873 @ 2.05p
15:37 320 @ 2.05p
15:36 114,195 @ 1.94p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page